Girindus signs collaboration agreement with RiboTask

Under the terms of the agreement, RiboTask will gain access to the worldwide sales and marketing team of Girindus, and Girindus through the collaboration with RiboTask will have the ability to offer its customers seamless manufacture of a wide variety of oligonucleotides from the milligram quantity to commercial kilogram quantities.

Mark Laskovics, president and COO of Girindus America, said: “Jesper Wengel, chairman of the board of RiboTask has long been recognized as one of the leaders in the oligonucleotide field. And RiboTask has been built into a world-class organization to provide a range of oligonucleotides, particularly oligonucleotides possessing complex sequences. We are delighted that our two organizations will work together to provide the best possible solution for our customers.”